Trexquant Investment LP Cidara Therapeutics, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$3.7 - $5.25 $57,076 - $80,986	-15,426 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$3.75 - $6.05 $65,321 - $105,384	-17,419 Reduced 53.03%	15,426 $80,000
Q1 2018 May 03, 2018	BUY	$4.0 - $8.15 $71,648 - $145,982	17,912 Added 119.95%	32,845 $131,000
Q4 2017 Feb 09, 2018	BUY	$6.35 - $8.75 $94,824 - $130,663	14,933	14,933 $102,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.